Home / Stock Quotes / PFIZERQuotes with Resistance & Support Market Information Pfizer Limited Stock Code: NSE » PFIZER AND BSE » 500680 4248.9 -27 (-0.6%) Details Technicals for 28-04-2025 Open 4288 Resistance 3 4538.26 Last close 4275.9 Resistance 2 4451.63 Today's high 4365 ...
It's said that Trump is a walking drama machine, raising tariffs today and praising China tomorrow, making stock investors feel like they are on a roller coaster every day. But if you have seen hisThe Art of Trade, and then take another look at hisGemini horoscope—Wow! This guy's appr...
Discover real-time Pfizer, Inc. Common Stock (PFE) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
NEW YORK--(BUSINESS WIRE)--Pfizer Inc.(NYSE:PFE) today provided its full-year 2025 guidance(1) and reaffirmed itsOctober 29, 2024full-year 2024 guidance(1). The accompanying presentation can be found atwww.pfizer.com/investors. Full-Year 2025 Revenue Guidance(1) Pfizeranticip...
s these clinical trials that lead to life-changing medicines. go to pfizer clinical trials site details how drugs are made the medicines available today have taken an average of 12 years to develop. with dedication, creativity, and science, we can significantly cut that time. biologics and ...
Stock Comparison Tools FAANG Stocks Gold ETFs Cash Equivalents Big Bank Stocks Big Pharma Stocks Retail Stocks Top Indexes Dow Jones S&P 500 Nasdaq Gold Bitcoin Market Outlook Today's Market US Economy Gold & Precious Metals Commodities Forex Editors' Picks Cryptocurrency Market Data Bond ETFs...
healthcare consumer utilities financials industrials stock comparison tools faang stocks gold etfs cash equivalents big bank stocks big pharma stocks retail stocks top indexes dow jones s&p 500 nasdaq gold bitcoin market outlook today's market us economy gold & precious metals commodities forex editors...
Pfizer Inc. (NYSE: PFE) reported exceptional financial results for fourth-quarter and full-year 2022 and provided 2023 financial guidance(4).
Pfizer Inc. reported financial results for the first quarter of 2024 and raised its Adjusted diluted EPS guidance while maintaining all other components of its 2024 financial guidance.
Pfizer to hold analyst and investor call at 8 a.m. EDT Monday, October 16, 2023 NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE:PFE) today announced that it has amended its supply agreement with the U.S. government for Paxlovid, the first oral antiviral pill approved by...